Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Roman

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Molecular Pharmacology|June 24, 2010
Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteinsLevi L Blazer, David L Roman, Alfred Chung, et al.
The Journal of Biological Chemistry|April 4, 2019
High-resolution structure of RGS17 suggests a role for Ca<sup>2+</sup> in promoting the GTPase-activating protein activity by RZ subfamily membersMonita Sieng, Michael P Hayes, Joseph B O'Brien, et al.
SLAS Discovery : Advancing Life Sciences R & D|January 20, 2018
Screen Targeting Lung and Prostate Cancer Oncogene Identifies Novel Inhibitors of RGS17 and Problematic Chemical SubstructuresChristopher R Bodle, Josephine H Schamp, Joseph B O'Brien, et al.
Frontiers in Pharmacology|September 23, 2022
Protein-protein interaction-based high throughput screening for adenylyl cyclase 1 inhibitors: Design, implementation, and discovery of a novel chemotypeTiffany S Dwyer, Joseph B O'Brien, Christopher P Ptak, et al.
Journal of Neurochemistry|December 17, 2009
Differential modulation of mu-opioid receptor signaling to adenylyl cyclase by regulators of G protein signaling proteins 4 or 8 and 7 in permeabilised C6 cells is Galpha subtype dependentJeffery N Talbot, David L Roman, Mary J Clark, et al.
BMC Pharmacology|May 26, 2009
A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screenRebecca A Roof, David L Roman, Samuel T Clements, et al.
Chemical Biology & Drug Design|July 22, 2008
Novel peptide ligands of RGS4 from a focused one-bead, one-compound libraryRebecca A Roof, Katarzyna Sobczyk-Kojiro, Anjanette J Turbiak, et al.
Journal of Natural Products|June 17, 2017
Natural Products Discovered in a High-Throughput Screen Identified as Inhibitors of RGS17 and as Cytostatic and Cytotoxic Agents for Lung and Prostate Cancer Cell LinesChristopher R Bodle, Duncan I Mackie, Michael P Hayes, et al.
Plos One|November 28, 2013
RABL6A, a novel RAB-like protein, controls centrosome amplification and chromosome instability in primary fibroblastsXuefeng Zhang, Jussara Hagen, Viviane P Muniz, et al.
British Journal of Pharmacology|September 16, 2021
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein TargetsStephen Ph Alexander, Eamonn Kelly, Alistair Mathie, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Molecular Pharmacology|June 24, 2010
Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteinsLevi L Blazer, David L Roman, Alfred Chung, et al.
The Journal of Biological Chemistry|April 4, 2019
High-resolution structure of RGS17 suggests a role for Ca<sup>2+</sup> in promoting the GTPase-activating protein activity by RZ subfamily membersMonita Sieng, Michael P Hayes, Joseph B O'Brien, et al.
SLAS Discovery : Advancing Life Sciences R & D|January 20, 2018
Screen Targeting Lung and Prostate Cancer Oncogene Identifies Novel Inhibitors of RGS17 and Problematic Chemical SubstructuresChristopher R Bodle, Josephine H Schamp, Joseph B O'Brien, et al.
Frontiers in Pharmacology|September 23, 2022
Protein-protein interaction-based high throughput screening for adenylyl cyclase 1 inhibitors: Design, implementation, and discovery of a novel chemotypeTiffany S Dwyer, Joseph B O'Brien, Christopher P Ptak, et al.
Journal of Neurochemistry|December 17, 2009
Differential modulation of mu-opioid receptor signaling to adenylyl cyclase by regulators of G protein signaling proteins 4 or 8 and 7 in permeabilised C6 cells is Galpha subtype dependentJeffery N Talbot, David L Roman, Mary J Clark, et al.
BMC Pharmacology|May 26, 2009
A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screenRebecca A Roof, David L Roman, Samuel T Clements, et al.
Chemical Biology & Drug Design|July 22, 2008
Novel peptide ligands of RGS4 from a focused one-bead, one-compound libraryRebecca A Roof, Katarzyna Sobczyk-Kojiro, Anjanette J Turbiak, et al.
Journal of Natural Products|June 17, 2017
Natural Products Discovered in a High-Throughput Screen Identified as Inhibitors of RGS17 and as Cytostatic and Cytotoxic Agents for Lung and Prostate Cancer Cell LinesChristopher R Bodle, Duncan I Mackie, Michael P Hayes, et al.
Plos One|November 28, 2013
RABL6A, a novel RAB-like protein, controls centrosome amplification and chromosome instability in primary fibroblastsXuefeng Zhang, Jussara Hagen, Viviane P Muniz, et al.
British Journal of Pharmacology|September 16, 2021
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein TargetsStephen Ph Alexander, Eamonn Kelly, Alistair Mathie, et al.
Pageof 5